Voloridge Investment Management
LKFT

Voloridge Investment Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Voloridge Investment Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$405K Sell
13,505
-30,351
-69% -$1M ﹤0.01% 954
2025
Q4 		$1.43M Sell
43,856
-43,716
-50% -$1.41M 0.01% 960
2025
Q3 		$3.03M Buy
87,572
+2,171
+3% +$69.4K 0.01% 853
2025
Q2 		$2.39M Buy
+85,401
New +$2.29M 0.01% 920
2024
Q2 		– Sell
-7,106
Closed -$229K – 1265
2024
Q1 		$229K Sell
7,106
-49,053
-87% -$1.82M ﹤0.01% 1105
2023
Q4 		$2.28M Buy
56,159
+48,703
+653% +$1.79M 0.01% 803
2023
Q3 		$258K Buy
+7,456
New +$290K ﹤0.01% 1299
2022
Q3 		– Sell
-4,159
Closed -$232K – 1476
2022
Q2 		$232K Buy
+4,159
New +$247K ﹤0.01% 1371
2022
Q1 		– Sell
-49,002
Closed -$2.7M – 1496
2021
Q4 		$2.7M Sell
49,002
-38,226
-44% -$1.99M 0.01% 950
2021
Q3 		$4.59M Sell
87,228
-578
-0.7% -$34.3K 0.03% 719
2021
Q2 		$6.05M Sell
87,806
-3,622
-4% -$276K 0.04% 568
2021
Q1 		$7.05M Buy
91,428
+6,626
+8% +$610K 0.05% 426
2020
Q4 		$8.39M Buy
84,802
+73,460
+648% +$8.98M 0.07% 323
2020
Q3 		$1.61M Buy
11,342
+5,244
+86% +$874K 0.01% 790
2020
Q2 		$1.2M Buy
6,098
+4,323
+244% +$895K 0.01% 787
2020
Q1 		$348K Sell
1,775
-8,927
-83% -$1.92M 0.01% 821
2019
Q4 		$2.21M Sell
10,702
-202
-2% -$37.3K 0.04% 470
2019
Q3 		$1.67M Buy
+10,904
New +$1.79M 0.03% 499

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Voloridge Investment Management's LKFT Position: Q1 2026 in Review

Voloridge Investment Management reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 69% in Q1 2026, selling an estimated $1M and leaving 13,505 shares worth $405K. The position accounts for ﹤0.01% of the portfolio, ranked #954.

Voloridge Investment Management first reported a position in LKFT in Q3 2019 and has held it in 18 quarters since. The position peaked at $8.39M in Q4 2020. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • Voloridge Investment Management held 13,505 shares of Lakefront Biotherapeutics American Depositary Shares worth $405K as of Q1 2026.
  • Voloridge Investment Management sold 30,351 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $1M.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Voloridge Investment Management's portfolio in Q1 2026, its #954 holding.
  • Voloridge Investment Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2019 and has held it in 18 quarters since.
  • Voloridge Investment Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $8.39M in Q4 2020.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.